Blog
RSS FeedPosted by Michael Wonder on 01 Jul 2022
New PBS listings from 1 July 2022
1 July 2022 - Vitrakvi (larotrectinib) will list for the first time for the treatment of adult and paediatric patients with ...
Posted by Michael Wonder on 30 Jun 2022
PBS listing for ‘Australian success story’ blood cancer drug
1 July 2022 - A pill that removes the need for chemotherapy for some cancer sufferers has been put on ...
Posted by Michael Wonder on 30 Jun 2022
Schedule of Pharmaceutical Benefits - 1 July 2022
1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 May 2022
Schedule of Pharmaceutical Benefits - 1 June 2022
1 June 2022 - The June 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 May 2022
New Zealand Pharmaceutical Schedule - 1 June 2022
1 June 2022 - The June 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 May 2022
Janssen’s psoriatic arthritis drug Tremfya gets insurance coverage
26 May 2022 - Janssen Korea said that the Ministry of Health and Welfare would begin to reimburse Tremfya, its ...
Posted by Michael Wonder on 19 May 2022
BMS’ Sprycel reimbursement criteria to be broadened for paediatric Philadelphia chromosome positive ALL
19 May 2022 - The state health insurance review agency said it would broaden the reimbursement criteria for Sprycel (dasatinib), ...
Posted by Michael Wonder on 16 May 2022
Spravato approved for reimbursement in Ireland for adults with treatment-resistant major depressive disorder
16 May 2022 - Janssen has announced that Spravato (esketamine) nasal spray has been granted reimbursement in Ireland for the ...
Posted by Michael Wonder on 10 May 2022
Fertility drug Rekovelle gets reimbursable in combo with hMG
10 May 2022 - Ferring’s Rekovelle (follitropin delta), a treatment to promote egg production in ovaries, became reimbursable when used ...
Posted by Michael Wonder on 03 May 2022
First million dollar medicine listed on the PBS
4 May 2022 - Zolgensma has the great honour of being the first medicine listed on the PBS with a ...
Posted by Michael Wonder on 03 May 2022
Boehringer Ingelheim Canada announces reimbursement for Ofev (nintedanib) in seven public drug plans for the treatment of progressive fibrosing interstitial lung diseases
3 May 2022 - Boehringer Ingelheim is pleased to announce that Ofev (nintedanib), is now available for public reimbursement in Quebec, ...
Posted by Michael Wonder on 02 May 2022
Prices of Tecentriq, Avastin go down due to broader insurance benefits
2 May 2022 - The Government granted health insurance benefits to the combination therapy of Tecentriq and Avastin to treat ...
Posted by Michael Wonder on 01 May 2022
COVID-19 oral treatment listed on PBS from 1 May 2022
1 May 2022 - This prescription only oral treatment has been found to be effective in treating mild to moderate ...
Posted by Michael Wonder on 01 May 2022
Schedule of Pharmaceutical Benefits - 1 May 2022
1 May 2022 - The May 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 May 2022
New Pharmaceutical Benefits Scheme listings to save patients millions
1 May 2022 - Health Minister Greg Hunt has announced a series of new Pharmaceutical Benefits Scheme listings which will save ...